© 1996 by Oxford University Press
Journal of the National Cancer Institute, Vol. 88, No. 20, 1472-1477,
October 16, 1996
© 1996 Oxford University Press
Excess Risk of Primary Liver Cancer in Patients With Diabetes Mellitus
Department of Cancer Epidemiology, University Hospital Uppsala, Sweden Department of Epidemiology, Harvard School of Public Health Boston, MA
International Epidemiology Institute, Rockville MD Division of Cancer Epidemiology and Genetics, National Cancer Institute Bethesda, MD
Department of Cancer Epidemiology, University Hospital Uppsala
Department of Internal Medicine, University Hospital Uppsala
Division of Cancer Epidemiology and Genetics, National Cancer Institute Uppsala
International Epidemiology Institute Uppsala
Professor Hans-Olov Adami, M.D., Ph.D., Department of Cancer Epidemiology, University Hospital, S-751 85 Uppsala, Sweden.
BACKGROUND:: Chronic infection with hepatitis B virus, alcohol consumption, and cirrhosis of the liver are recognized risk factors for primary liver cancer. A few, but not all, studies have suggested that diabetes mellitus also increases risk for this cancer.
PURPOSE:: We conducted a population-based cohort study to analyze the risk of developing primary liver cancer and biliary tract (gallbladder, extrahepatic bile ducts, and ampulla of Vater) cancers among patients with diabetes.
METHODS:: A cohort of 153 852 patients with a hospital discharge diagnosis of diabetes in the period from 1965 through 1983 was identified by use of the Swedish In-patient Register. Follow-up for these patients extended from the date of cohort entry through December 31, 1989. Incident cases of cancer during follow-up were identified through the Swedish Cancer Registry. To minimize the impact of selection bias, we excluded from the analysis patients who were diagnosed with liver and biliary tract cancers during the first year of follow-up. Standardized incidence ratios (SIRs) and their 95% confidence intervals (CIs) were computed by use of nationwide rates of liver and biliary tract cancers, adjusted for age, sex, and calendar year, for comparison.
RESULTS:: During 1–24 years of follow-up, 819 incident cancers in the combined category of primary liver (n = 533) and biliary tract (n = 286) were identified in the cohort, yielding an overall SIR of 2.5 (95% CI = 2.3–2.6). The risk was higher in men (SIR = 3.2; 95% CI = 2.9–3.6) than in women (SIR = 2.0; 95% CI = 1.8–2.2). The incidence of primary liver cancer alone was increased fourfold (SIR = 4.1; 95% CI = 3.8–4.5); again, the risk was higher in men (SIR = 4.7; 95% CI = 4.2–5.2) than in women (SIR = 3.4; 95% CI = 2.9–3.9). Smaller increases in risk were seen for cancers of the gallbladder, the extrahepatic bile ducts, and the ampulla of Vater. After exclusion of diabetic patients with concomitant diseases that predispose to primary liver cancer, such as alcoholism, cirrhosis, and hepatitis, the persistence of an approximately threefold excess risk was observed.
CONCLUSIONS:: Our findings suggest that patients with diabetes are at increased risk of developing primary liver cancer and perhaps cancers of the biliary tract. The mechanisms involved in the association of diabetes and liver cancer remain to be clarified. Additional studies are needed to determine whether patients with insulin-dependent diabetes mellitus and those with non-insulin-dependent diabetes mellitus differ in their risk for primary liver cancer or whether the risk is affected by the type of diabetes treatment. [J Natl Cancer Inst 1996;88:1472-77]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-S. Wang, W.-J. Yao, T.-T. Chang, S.-T. Wang, and P. Chou The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2054 - 2060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Polesel, A. Zucchetto, M. Montella, L. Dal Maso, A. Crispo, C. La Vecchia, D. Serraino, S. Franceschi, and R. Talamini The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma Ann. Onc., February 1, 2009; 20(2): 353 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-W. Yu, W.-L. Shih, C.-L. Lin, C.-J. Liu, J.-W. Jian, K.-S. Tsai, and C.-J. Chen Body-Mass Index and Progression of Hepatitis B: A Population-Based Cohort Study in Men J. Clin. Oncol., December 1, 2008; 26(34): 5576 - 5582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J F Ludvigsson, O Olen, M Bell, A Ekbom, and S M Montgomery Coeliac disease and risk of sepsis Gut, August 1, 2008; 57(8): 1074 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fujimiya, H. Kojima, M. Ichinose, R. Arai, H. Kimura, A. Kashiwagi, and L. Chan Fusion of proinsulin-producing bone marrow-derived cells with hepatocytes in diabetes PNAS, March 6, 2007; 104(10): 4030 - 4035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Tolman, V. Fonseca, A. Dalpiaz, and M. H. Tan Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease Diabetes Care, March 1, 2007; 30(3): 734 - 743. [Full Text] [PDF]
|
|
|
|
|
|
J A Davila, R O Morgan, Y Shaib, K A McGlynn, and H B El-Serag Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study Gut, April 1, 2005; 54(4): 533 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamagata, Y. Kiyohara, S. Nakamura, M. Kubo, Y. Tanizaki, T. Matsumoto, K. Tanaka, I. Kato, T. Shirota, and M. Iida Impact of Fasting Plasma Glucose Levels on Gastric Cancer Incidence in a General Japanese Population: The Hisayama Study Diabetes Care, April 1, 2005; 28(4): 789 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Tolman, V. Fonseca, M. H. Tan, and A. Dalpiaz Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus Ann Intern Med, December 21, 2004; 141(12): 946 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Coughlin, E. E. Calle, L. R. Teras, J. Petrelli, and M. J. Thun Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults Am. J. Epidemiol., June 15, 2004; 159(12): 1160 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zendehdel, O. Nyren, C.-G. Ostenson, H.-O. Adami, A. Ekbom, and W. Ye Cancer Incidence in Patients With Type 1 Diabetes Mellitus: A Population-Based Cohort Study in Sweden J Natl Cancer Inst, December 3, 2003; 95(23): 1797 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. El-Serag, J. A. Davila, N. J. Petersen, and K. A. McGlynn The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update Ann Intern Med, November 18, 2003; 139(10): 817 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Kim, K. J. Woodcroft, S. G. Kim, and R. F. Novak INSULIN AND GLUCAGON SIGNALING IN REGULATION OF MICROSOMAL EPOXIDE HYDROLASE EXPRESSION IN PRIMARY CULTURED RAT HEPATOCYTES Drug Metab. Dispos., October 1, 2003; 31(10): 1260 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Verlato, G. Zoppini, E. Bonora, and M. Muggeo Mortality From Site-Specific Malignancies in Type 2 Diabetic Patients From Verona Diabetes Care, April 1, 2003; 26(4): 1047 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Kim, K. J. Woodcroft, and R. F. Novak Insulin and Glucagon Regulation of Glutathione S-Transferase Expression in Primary Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 353 - 361. [Abstract] [Full Text]
|
|
|
|
|
|
B. Balkau, H. S. Kahn, D. Courbon, E. Eschwège, and P. Ducimetière Hyperinsulinemia Predicts Fatal Liver Cancer but Is Inversely Associated With Fatal Cancer at Some Other Sites: The Paris Prospective Study Diabetes Care, May 1, 2001; 24(5): 843 - 849. [Abstract] [Full Text]
|
|
|
|
|
|
P. Lagiou, H. Kuper, S. O. Stuver, A. Tzonou, D. Trichopoulos, and H.-O. Adami Role of Diabetes Mellitus in the Etiology of Hepatocellular Carcinoma J Natl Cancer Inst, July 5, 2000; 92(13): 1096 - 1099. [Full Text] [PDF]
|
|
|
|
 |
|
 A S KASHYAP and S. KASHYAP Hepatocellular carcinoma Postgrad. Med. J., July 1, 2000; 76(897): 453d - 453. [Full Text]
|
|
|
|
 |
|
 S. WILBRAND, A. EKBOM, and B. GERDIN Cancer Incidence in Patients Treated Surgically for Dupuytren's Contracture J Hand Surg Eur Vol., June 1, 2000; 25(3): 283 - 287. [Abstract] [PDF]
|
|